Company news
Twist Bioscience Corporation news in 2024
Twist Bioscience Corporation's news releases, calls and decks from 2024, newest first.
Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference
December 18, 2024
Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results
November 17, 2024
Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference
November 13, 2024
Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics
October 29, 2024
Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024
October 23, 2024
Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash
October 21, 2024
Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer
October 14, 2024
Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance
September 11, 2024
Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels
September 8, 2024
Twist Bioscience to Present at Baird Global Healthcare Conference 2024
August 26, 2024
Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb
August 7, 2024
Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis
August 4, 2024
Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results
August 1, 2024
Twist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody Libraries
July 17, 2024
Twist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024
July 10, 2024
Twist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express Antibodies
July 9, 2024
Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A
July 8, 2024
Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor
June 5, 2024
Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety
June 3, 2024
Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
May 12, 2024
Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
May 1, 2024
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
April 17, 2024
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
March 27, 2024
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
March 4, 2024
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
February 5, 2024
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
February 5, 2024
Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT
February 4, 2024
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
February 1, 2024
Twist Bioscience Expands Express Genes Rapid Synthesis Service
January 23, 2024
Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024
January 15, 2024
Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
January 7, 2024
Twist Bioscience Appoints Adam Laponis as Chief Financial Officer
January 4, 2024
Calls in 2024
Decks in 2024
- Q1 FY2024 Earnings Presentation
Earnings · 17 slides · February 2024